Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03793179
Brief Title: Firstline Pembrolizumab Alone or in Combination With Pemetrexed and Carboplatin in Induction/Maintenance or Postprogression in Treating Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

First Submitted : January 3, 2019
First Submitted that Met QC Criteria : January 3, 2019
First Posted : January 4, 2019

Last Update Submitted that Met QC Criteria : November 6, 2019
Last Update Posted : November 7, 2019